Physician profile
Edward V Becker
NPI 1962515858
$2,219.69
in general payments reported to CMS, 2019-2025
23 companies · $358 in 2025
The $358 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,173 · 2020: $223 · 2021: $67.48 · 2022: $59.52 · 2023: $307 · 2024: $30.49 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $461.41 | 2019-2020 | |
| Abbvie INC. | $438.66 | 2019-2025 | Botox |
| Novartis Pharmaceuticals Corporation | $209.29 | 2019-2025 | |
| Janssen Biotech, INC. | $152.97 | 2019-2021 | |
| Genzyme Corporation | $152.06 | 2019-2025 | |
| Allergan, INC. | $125.67 | 2019-2021 | |
| Ucb, INC. | $115.01 | 2019-2023 | Cimzia |
| Leo Pharma INC. | $89.06 | 2019-2020 | |
| Genentech USA, INC. | $74.47 | 2019 | |
| Angiodynamics, INC. | $60.51 | 2023 | Venacure 1470 Pro |
| Vericel Corporation | $58.70 | 2025 | Maci |
| Amgen INC. | $49.31 | 2019 | |
| Lilly USA, LLC | $28.24 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $24.58 | 2020 | |
| Dermira, INC. | $24.36 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $24.18 | 2019 | |
| Galderma Laboratories, L.P. | $23.69 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.07 | 2022 | |
| Organon LLC | $21.72 | 2025 | Vtama |
| Pierre Fabre Pharmaceuticals, INC. | $18.76 | 2019 | |
| Mission Pharmacal Company | $15.69 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.61 | 2019 | |
| Pfizer INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.